Evaluating Intracellular Location and ROS Scavenging by Manganese Dioxide Nanoparticles in Chondrocytes

Area of Science:

• Biomedical Engineering
• Nanomedicine
• Cell Biology

Background:

• Osteoarthritis (OA) is characterized by oxidative stress due to reactive oxygen species (ROS) imbalance.
• Conventional antioxidants have limitations in stability and bioavailability for OA treatment.
• Engineered manganese dioxide nanoparticles (MnO2) show potential for ROS scavenging and chondroprotection.

Purpose of the Study:

• To investigate the cellular uptake mechanisms of MnO2 nanoparticles in chondrocytes.
• To determine the subcellular fate and ROS scavenging activity of MnO2 within chondrocytes.
• To assess the impact of MnO2 on mitochondrial function in chondrocytes.

Main Methods:

• Evaluated MnO2 uptake via temperature dependence and endocytic pathway inhibition in bovine chondrocytes.
• Assessed MnO2 ROS scavenging using acellular and cellular systems.
• Utilized HyPer7 genetically encoded probes to measure H2O2 levels in mitochondria and cytosol.

Main Results:

• MnO2 demonstrated catalase-like effects, reducing oxidative stress in chondrocytes.
• MnO2 entered chondrocytes through both energy-dependent and independent pathways.
• MnO2 localized to mitochondria, scavenging H2O2 in mitochondrial matrix, intermembrane space, and cytosol without impairing respiration.

Conclusions:

• MnO2 nanoparticles effectively scavenge intracellular ROS, particularly within mitochondria.
• The study provides mechanistic insights into MnO2 uptake, localization, and function in chondrocytes.
• MnO2 represents a promising therapeutic strategy for mitigating oxidative stress in osteoarthritis.